Skip to main content

Li Dean Y's Form 4 filing

Merck & Co., Inc. (MRK) · filed Feb 6, 2026

Accession no.
0000310158-26-000036
Filed
Feb 6, 2026
Trade date
Feb 4, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.79M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Li Dean YCIK 0001837016Officer (Executive VP & President, MRL)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 4, 2026Common StockMOption exerciseAcquired+15,087$56.04+$845,475.48117,357.05Direct
Feb 4, 2026Common StockSSaleDisposed−15,087$118.77−$1,791,882.99102,270.05Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 4, 2026Common StockMOption exerciseDisposed−15,087$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)